img

Global Raltegravir Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Raltegravir Market Research Report 2024

Raltegravir (RAL), sold under the brand name Isentress, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS.
According to Mr Accuracy reports new survey, global Raltegravir market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Raltegravir market research.
Key manufacturers engaged in the Raltegravir industry include Merck & Co. and Hetero etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Raltegravir were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Raltegravir market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Raltegravir market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck & Co.
Hetero
Segment by Type
Tablet
Oral Powder

Segment by Application


Hospital
Drug Store
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Raltegravir report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Raltegravir Market Overview
1.1 Product Overview and Scope of Raltegravir
1.2 Raltegravir Segment by Type
1.2.1 Global Raltegravir Market Value Comparison by Type (2024-2034)
1.2.2 Tablet
1.2.3 Oral Powder
1.3 Raltegravir Segment by Application
1.3.1 Global Raltegravir Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Others
1.4 Global Raltegravir Market Size Estimates and Forecasts
1.4.1 Global Raltegravir Revenue 2018-2029
1.4.2 Global Raltegravir Sales 2018-2029
1.4.3 Global Raltegravir Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Raltegravir Market Competition by Manufacturers
2.1 Global Raltegravir Sales Market Share by Manufacturers (2018-2024)
2.2 Global Raltegravir Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Raltegravir Average Price by Manufacturers (2018-2024)
2.4 Global Raltegravir Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Raltegravir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Raltegravir, Product Type & Application
2.7 Raltegravir Market Competitive Situation and Trends
2.7.1 Raltegravir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Raltegravir Players Market Share by Revenue
2.7.3 Global Raltegravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Raltegravir Retrospective Market Scenario by Region
3.1 Global Raltegravir Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Raltegravir Global Raltegravir Sales by Region: 2018-2029
3.2.1 Global Raltegravir Sales by Region: 2018-2024
3.2.2 Global Raltegravir Sales by Region: 2024-2029
3.3 Global Raltegravir Global Raltegravir Revenue by Region: 2018-2029
3.3.1 Global Raltegravir Revenue by Region: 2018-2024
3.3.2 Global Raltegravir Revenue by Region: 2024-2029
3.4 North America Raltegravir Market Facts & Figures by Country
3.4.1 North America Raltegravir Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Raltegravir Sales by Country (2018-2029)
3.4.3 North America Raltegravir Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Raltegravir Market Facts & Figures by Country
3.5.1 Europe Raltegravir Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Raltegravir Sales by Country (2018-2029)
3.5.3 Europe Raltegravir Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Raltegravir Market Facts & Figures by Country
3.6.1 Asia Pacific Raltegravir Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Raltegravir Sales by Country (2018-2029)
3.6.3 Asia Pacific Raltegravir Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Raltegravir Market Facts & Figures by Country
3.7.1 Latin America Raltegravir Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Raltegravir Sales by Country (2018-2029)
3.7.3 Latin America Raltegravir Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Raltegravir Market Facts & Figures by Country
3.8.1 Middle East and Africa Raltegravir Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Raltegravir Sales by Country (2018-2029)
3.8.3 Middle East and Africa Raltegravir Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Raltegravir Sales by Type (2018-2029)
4.1.1 Global Raltegravir Sales by Type (2018-2024)
4.1.2 Global Raltegravir Sales by Type (2024-2029)
4.1.3 Global Raltegravir Sales Market Share by Type (2018-2029)
4.2 Global Raltegravir Revenue by Type (2018-2029)
4.2.1 Global Raltegravir Revenue by Type (2018-2024)
4.2.2 Global Raltegravir Revenue by Type (2024-2029)
4.2.3 Global Raltegravir Revenue Market Share by Type (2018-2029)
4.3 Global Raltegravir Price by Type (2018-2029)
5 Segment by Application
5.1 Global Raltegravir Sales by Application (2018-2029)
5.1.1 Global Raltegravir Sales by Application (2018-2024)
5.1.2 Global Raltegravir Sales by Application (2024-2029)
5.1.3 Global Raltegravir Sales Market Share by Application (2018-2029)
5.2 Global Raltegravir Revenue by Application (2018-2029)
5.2.1 Global Raltegravir Revenue by Application (2018-2024)
5.2.2 Global Raltegravir Revenue by Application (2024-2029)
5.2.3 Global Raltegravir Revenue Market Share by Application (2018-2029)
5.3 Global Raltegravir Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Corporation Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Raltegravir Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck & Co. Raltegravir Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 Hetero
6.2.1 Hetero Corporation Information
6.2.2 Hetero Description and Business Overview
6.2.3 Hetero Raltegravir Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Hetero Raltegravir Product Portfolio
6.2.5 Hetero Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Raltegravir Industry Chain Analysis
7.2 Raltegravir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Raltegravir Production Mode & Process
7.4 Raltegravir Sales and Marketing
7.4.1 Raltegravir Sales Channels
7.4.2 Raltegravir Distributors
7.5 Raltegravir Customers
8 Raltegravir Market Dynamics
8.1 Raltegravir Industry Trends
8.2 Raltegravir Market Drivers
8.3 Raltegravir Market Challenges
8.4 Raltegravir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Raltegravir Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Raltegravir Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Raltegravir Market Competitive Situation by Manufacturers in 2022
Table 4. Global Raltegravir Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Raltegravir Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Raltegravir Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Raltegravir Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Raltegravir Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Raltegravir, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Raltegravir, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Raltegravir, Product Type & Application
Table 12. Global Key Manufacturers of Raltegravir, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Raltegravir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Raltegravir as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Raltegravir Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Raltegravir Sales by Region (2018-2024) & (K Units)
Table 18. Global Raltegravir Sales Market Share by Region (2018-2024)
Table 19. Global Raltegravir Sales by Region (2024-2029) & (K Units)
Table 20. Global Raltegravir Sales Market Share by Region (2024-2029)
Table 21. Global Raltegravir Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Raltegravir Revenue Market Share by Region (2018-2024)
Table 23. Global Raltegravir Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Raltegravir Revenue Market Share by Region (2024-2029)
Table 25. North America Raltegravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Raltegravir Sales by Country (2018-2024) & (K Units)
Table 27. North America Raltegravir Sales by Country (2024-2029) & (K Units)
Table 28. North America Raltegravir Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Raltegravir Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Raltegravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Raltegravir Sales by Country (2018-2024) & (K Units)
Table 32. Europe Raltegravir Sales by Country (2024-2029) & (K Units)
Table 33. Europe Raltegravir Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Raltegravir Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Raltegravir Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Raltegravir Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Raltegravir Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Raltegravir Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Raltegravir Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Raltegravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Raltegravir Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Raltegravir Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Raltegravir Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Raltegravir Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Raltegravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Raltegravir Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Raltegravir Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Raltegravir Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Raltegravir Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Raltegravir Sales (K Units) by Type (2018-2024)
Table 51. Global Raltegravir Sales (K Units) by Type (2024-2029)
Table 52. Global Raltegravir Sales Market Share by Type (2018-2024)
Table 53. Global Raltegravir Sales Market Share by Type (2024-2029)
Table 54. Global Raltegravir Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Raltegravir Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Raltegravir Revenue Market Share by Type (2018-2024)
Table 57. Global Raltegravir Revenue Market Share by Type (2024-2029)
Table 58. Global Raltegravir Price (USD/Unit) by Type (2018-2024)
Table 59. Global Raltegravir Price (USD/Unit) by Type (2024-2029)
Table 60. Global Raltegravir Sales (K Units) by Application (2018-2024)
Table 61. Global Raltegravir Sales (K Units) by Application (2024-2029)
Table 62. Global Raltegravir Sales Market Share by Application (2018-2024)
Table 63. Global Raltegravir Sales Market Share by Application (2024-2029)
Table 64. Global Raltegravir Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Raltegravir Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Raltegravir Revenue Market Share by Application (2018-2024)
Table 67. Global Raltegravir Revenue Market Share by Application (2024-2029)
Table 68. Global Raltegravir Price (USD/Unit) by Application (2018-2024)
Table 69. Global Raltegravir Price (USD/Unit) by Application (2024-2029)
Table 70. Merck & Co. Corporation Information
Table 71. Merck & Co. Description and Business Overview
Table 72. Merck & Co. Raltegravir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Merck & Co. Raltegravir Product
Table 74. Merck & Co. Recent Developments/Updates
Table 75. Hetero Corporation Information
Table 76. Hetero Description and Business Overview
Table 77. Hetero Raltegravir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Hetero Raltegravir Product
Table 79. Hetero Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Raltegravir Distributors List
Table 83. Raltegravir Customers List
Table 84. Raltegravir Market Trends
Table 85. Raltegravir Market Drivers
Table 86. Raltegravir Market Challenges
Table 87. Raltegravir Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Raltegravir
Figure 2. Global Raltegravir Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Raltegravir Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Oral Powder Product Picture
Figure 6. Global Raltegravir Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Raltegravir Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Others
Figure 11. Global Raltegravir Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Raltegravir Market Size (2018-2029) & (US$ Million)
Figure 13. Global Raltegravir Sales (2018-2029) & (K Units)
Figure 14. Global Raltegravir Average Price (USD/Unit) & (2018-2029)
Figure 15. Raltegravir Report Years Considered
Figure 16. Raltegravir Sales Share by Manufacturers in 2022
Figure 17. Global Raltegravir Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Raltegravir Players: Market Share by Revenue in 2022
Figure 19. Raltegravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Raltegravir Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Raltegravir Sales Market Share by Country (2018-2029)
Figure 22. North America Raltegravir Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Raltegravir Sales Market Share by Country (2018-2029)
Figure 26. Europe Raltegravir Revenue Market Share by Country (2018-2029)
Figure 27. Germany Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Raltegravir Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Raltegravir Revenue Market Share by Region (2018-2029)
Figure 34. China Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Raltegravir Sales Market Share by Country (2018-2029)
Figure 45. Latin America Raltegravir Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Raltegravir Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Raltegravir Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Raltegravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Raltegravir by Type (2018-2029)
Figure 55. Global Revenue Market Share of Raltegravir by Type (2018-2029)
Figure 56. Global Raltegravir Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Raltegravir by Application (2018-2029)
Figure 58. Global Revenue Market Share of Raltegravir by Application (2018-2029)
Figure 59. Global Raltegravir Price (USD/Unit) by Application (2018-2029)
Figure 60. Raltegravir Value Chain
Figure 61. Raltegravir Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed